MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q2 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,005,000 | +265.5% | 30,500 | +272.6% | 0.07% | +52.1% |
| Q2 2016 | $275,000 | +5.8% | 8,186 | 0.0% | 0.05% | -5.9% |
| Q1 2016 | $260,000 | -45.6% | 8,186 | -51.0% | 0.05% | -60.2% |
| Q2 2015 | $478,000 | -91.1% | 16,700 | -91.1% | 0.13% | -68.5% |
| Q1 2014 | $5,344,000 | -47.3% | 188,030 | -28.4% | 0.41% | -53.2% |
| Q4 2013 | $10,142,000 | -33.7% | 262,600 | -42.5% | 0.87% | -31.3% |
| Q3 2013 | $15,302,000 | +35.0% | 456,500 | +23.9% | 1.26% | +26.9% |
| Q2 2013 | $11,334,000 | – | 368,480 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |